Ex-CEO's Counterclaims Not Allowed, Insys Trustee Says
The liquidation trustee of Insys Therapeutics on Tuesday asked a Delaware bankruptcy judge for an injunction preventing the pharmaceutical company's former CEO Michael L. Babich from pursuing counterclaims in a clawback...To view the full article, register now.
Already a subscriber? Click here to view full article